Evidence map›Paper›PMID 30144432›Full record

ArticleGastroenterology2018

Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.

Sandy Feng, John C Bucuvalas, Anthony J Demetris, Bryna E Burrell, Katherine M Spain, Sai Kanaparthi, John C Magee, David Ikle, Andrew Lesniak, Juan J Lozano and 16 more

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 154 citations in OpenAlex.

  1. IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Trial
  2. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Trial
  3. Review
  4. Article
  5. Single-cell transcriptional landscape of liver transplant rejection reveals tissue persistence of clonally expanded, treatment-resistant T cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  6. Article
  7. Effects ofOpen life sciences · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Risk factors associated with diabetes after liver transplant.Archives of endocrinology and metabolism · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 19 institutions in 3 countries.

Sandy FengDivision of Transplantation, Department of Surgery, University of California San Francisco, San Francisco, California. Electronic address: sandy.feng@ucsf.edu.
John C BucuvalasPediatric Liver Care Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Anthony J DemetrisDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Bryna E BurrellThe Immune Tolerance Network, Bethesda, Maryland.
Katherine M SpainRho, Inc, Chapel Hill, North Carolina.
Sai KanaparthiThe Immune Tolerance Network, Bethesda, Maryland.
John C MageeSection of Transplant Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan.
David IkleRho, Inc, Chapel Hill, North Carolina.
Andrew LesniakDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Juan J LozanoBiomedical Research Center in Hepatic and Digestive Diseases, Carlos III Health Institute, Barcelona, Spain.
Estella M AlonsoSiragusa Transplantation Center, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Robert A BrayDepartment of Pathology, Emory University Hospital, Atlanta, Georgia.
Nancy E BridgesTransplantation Branch, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, Rockville, Maryland.
Edward DooDivision of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland; Department of Pathology, Emory University Hospital, Atlanta, Georgia.
Howard M GebelDepartment of Pathology, Emory University Hospital, Atlanta, Georgia.
Nitika A GuptaDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Ryan W HimesSection of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas.
Annette M JacksonDivision of Immunogenetics and Transplantation Immunology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Steven J LobrittoCenter for Liver Diseases and Transplantation, Department of Surgery, Columbia University Medical Center, New York, New York.
George V MazariegosHillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania.
Vicky L NgDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Transplant and Regenerative Medicine Center, Toronto, Ontario, Canada.
Elizabeth B RandLiver Transplant Program, The Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania.
Averell H SherkerSiragusa Transplantation Center, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Shikha SundaramDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.
Yumirle P TurmelleDivision of Gastroenterology, Hepatology, and Nutrition, St. Louis Children's Hospital, St. Louis, Missouri.
Alberto Sanchez-FueyoInstitute of Liver Studies, King's College, London, London, United Kingdom.
Emory University Hospital · USImmune Tolerance Network · USLurie Children's Hospital · USRho (United States) · USUniversity of Pittsburgh · USChildren's Hospital Colorado · USChildren's Hospital of Philadelphia · USChildren's Hospital of Pittsburgh · USCincinnati Children's Hospital Medical Center · USColumbia University Irving Medical Center · USEmory University · USInstituto de Salud Carlos III · ESJohns Hopkins University · USKing's College London · GBNational Institute of Allergy and Infectious Diseases · USSt. Louis Children's Hospital · USTexas Children's Hospital · USUniversity of California, San Francisco · USUniversity of Michigan–Ann Arbor · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant RecipientsU01AI100807 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FENG, SANDY · 2012 to 2016
$9.5M
Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant RecipientsU01AI104347 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FENG, SANDY · 2013 to 2017
$4.8M
Medical Research Council MC_PC_15108NIAID NIH HHS U01 AI100807NIAID NIH HHS U01 AI104347NIAID NIH HHS UM1 AI109565
6 · The paper itself

Abstract

BACKGROUND &

aimsA substantial proportion of pediatric liver transplant recipients develop subclinical chronic allograft injury. We studied whether there are distinct patterns of injury based on histopathologic features and identified associated immunologic profiles.

methodsWe conducted a cross-sectional study of 157 stable, long-term pediatric recipients of transplanted livers (70 boys; > 6 years old at time of transplantation; mean, 8.9 ± 3.46 years after liver transplantation) who underwent liver biopsy analysis from August 13, 2012, through May 1, 2014. Participants had received livers from a living or deceased donor and had consistently normal results from liver tests. Liver biopsy specimens were scored by a central pathologist; an unsupervised hierarchical cluster analysis of histologic features was used to sort biopsy samples into 3 clusters. We conducted transcriptional and cytometric analyses of liver tissue samples and performed a systems biology analysis that incorporated clinical, serologic, histologic, and transcriptional data.

resultsThe mean level of alanine aminotransferase in participants was 27.6 ± 14.57 U/L, and the mean level of γ-glutamyl transferase was 17.4 ± 7.93 U/L. Cluster 1 was characterized by interface activity (n = 34), cluster 2 was characterized by periportal or perivenular fibrosis without interface activity (n = 45), and cluster 3 had neither feature (n = 78). We identified a module of genes whose expression correlated with levels of alanine aminotransferase, class II donor-specific antibody, portal inflammation, interface activity, perivenular inflammation, portal and perivenular fibrosis, and cluster assignment. The module was enriched in genes that regulate T-cell-mediated rejection (TCMR) of liver and other transplanted organs. Functional pathway analysis showed overrepresentation of TCMR gene sets for cluster 1 but not clusters 2 or 3.

conclusionIn an analysis of biopsies from an apparently homogeneous group of stable, long-term pediatric liver transplant recipients with consistently normal liver test results, we found evidence of chronic graft injury (inflammation and/or fibrosis). Biopsy samples with interface activity had a gene expression pattern associated with TCMR.

Indexed as

AdolescentAllograftsBiopsyChildChronic DiseaseCross-Sectional StudiesFemaleGraft RejectionHumansLiverLiver Function TestsLiver TransplantationMaleTime FactorsYoung AdultALTDSAImmune ResponsePrognostic Factor

Identifiers

PMID30144432
PMCPMC6279538
OpenAlexW2888442197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.